Intended for US healthcare professionals only.

Small. Light. Designed for everyday life.

Novocure's Optune system is small and lightweight, at just 2.7 pounds.1

Hover over to explore the Optune® system

Optune system components

The complete system includes a portable electric field generator, transducer arrays, rechargeable batteries, and more.

Contents of the Optune® system: Electric field generator

Electric field generator

The portable field generator can be carried with you to generate Tumor Treating Fields (TTFields) as you go about your day.

Contents of the Optune® system: Transducer arrays

Transducer array

Sterile, single-use transducer arrays are connected to the electric field generator to deliver therapy. Transducer arrays should be changed at least 2 times per week (every 4 days at most).

Contents of the Optune® system: Connection cable and box

Connection cable and box

Black and white coded sockets on the cable box help ensure that transducer arrays are properly connected.

Contents of the Optune® system: Easy-access sleeve bag

Easy access sleeve bag

Openings conveniently located at the top and bottom make it easy to reach device controls.

Contents of the Optune® system: Convertible, 5-in-1 bag

Convertible, 5-in-1 bag

This bag can be worn 5 different ways and has additional battery storage, making it ideal for on-the-go use.

The Optune system is designed for enhanced carrying comfort and usability:

  • Easy-grip texture allows for excellent handling
  • Battery indicator displays power and alerts patients when it’s time to change the battery
  • Light-detecting sensor auto-dims the device and the charger in the dark

Other components include2:

  • Portable batteries: 4 batteries are provided with each kit; each battery lasts for 2 to 3 hours
  • Charger for portable batteries: Batteries will need to be recharged for 2 to 4 hours. The batteries can be charged and used many times for about 6 to 9 months
  • Plug-in power supply and power cords: New “No-Stop Swap” enables patients to swap batteries or power source without disrupting delivery of TTFields

TTFields, Tumor Treating Fields.

References: 1. Kinzel A, Ambrogi M, Varshaver M, Kirson ED. Tumor treating fields for glioblastoma treatment: patient satisfaction and compliance with the second-generation Optune® system. Clin Med Insights Oncol. 2019;13:1-7. 2. Optune patient information and operation manual. 2019. QSD-QR-704. REV 05.

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).